Should We Sequence the DNA of Every Cancer Patient?
By Antonio Regalado,
MIT Technology Review
| 06. 14. 2016
A startup called Strata Oncology says it plans to give away advanced genetic tests to 100,000 patients struggling with cancer. But there's a profit motive: it hopes to identify patients with specific rare DNA errors and steer them to drug companies.
Strata, which was founded last year and has raised $12 million from investors, says it is set up to run 50,000 next-generation sequencing tests a year. Such tests probe the DNA of tumor tissue, searching for mutations in hundreds of genes at once, hoping to surface clues about what drug a patient should be taking.
Similar tests are already offered commercially to doctors by several companies, including Foundation Medicine of Cambridge, Massachusetts, and can cost $5,000 each.
Continue reading on MIT Technology Review
Image via Wikipedia
Related Articles
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...
By Jessica Hamzelou, MIT Technology Review | 07.23.2026
When it comes to organ donation, time is everything. As soon as an organ has been carefully removed from a donor’s body, it starts to deteriorate. Surgeons have a matter of hours to get it into a recipient. Leave...
By Dhruv Mehrotra , Wired | 08.03.2026
On March 13, 2025, Hugo Moreno-Mendez arrived at the McLennan County Probation Department in Waco, Texas, expecting a routine probation check-in. Instead, Immigration and Customs Enforcement officers were waiting to arrest him.
According to a criminal complaint reviewed by WIRED...
By Nina Agrawal, The New York Times | 07.16.2026
Ethan White first noticed something was wrong at drum practice. A snare drummer in the University of Michigan marching band, he suddenly could no longer feel the muscles in his right hand gripping the drumstick. Weeks earlier, he had marched...